Janus Henderson Group PLC Mirum Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,766,109 shares of MIRM stock, worth $213 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
4,766,109
Previous 4,581,642
4.03%
Holding current value
$213 Million
Previous $189 Million
13.33%
% of portfolio
0.12%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$303 Million19.27% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$145 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$125 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$113 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.53MShares$113 Million2.42% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...